LIXTE Biotechnology Holdings (ticker: LIXT and LIXTW), a Nasdaq-listed company, announced on September 10 that it has made an initial purchase of 10.5 bitcoins and 300 ethereum worth approximately $2.60 million as part of its capital diversification strategy.
According to the announcement, cryptocurrencies currently account for 43.6% of LIXTE's capital holdings, and the company's board of directors has approved an increase in the allocation of cryptocurrencies to 50%. Geordan Pursglove, chairperson and CEO of LIXTE, said the move is aimed at building a balanced and flexible digital asset strategy that enhances the company's resilience and long-term growth potential in the digital economy.
Previously, it was reported that US-listed biotech company LIXTE plans to allocate up to 25% of its capital reserves to digital assets such as bitcoin.
US-listed company LIXTE spent $2.60 million to buy cryptocurrency
2025-09-11 00:30:54
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Previous article：
美股上市公司LIXTE斥资260万美元购入加密货币Next article：
Arthur Hayes买入57.89万枚ENA，约合46.77万美元
